Wong Shelly
Transaction: 07/01/2026
SELL
Change
-1,404
Price
$2.04
Filing
07/06/2026
Type
SELL
ALX Oncology Holdings Inc.
ALXO • Biotechnology
$2.01
▼ -0.02 (-0.99%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$272.64M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.2Healthy liquidity · 2.07Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:49 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.01
Change-0.99%
Shares Out135.64M
Market Cap$272.64M
Enterprise Value$144.11M
52W Range0.63 - 2.66
Beta0.43
P/E-3.37
P/B2.00
P/FCF-3.04
EV/EBITDA-1.78
EV/FCF-1.61
Price$2.01
Change-0.99%
Shares Out135.64M
Market Cap$272.64M
Enterprise Value$144.11M
52W Range0.63 - 2.66
Beta0.43
P/E-3.37
P/B2.00
P/FCF-3.04
EV/EBITDA-1.78
EV/FCF-1.61
Earnings Yield-29.67%
FCF Yield-32.88%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.20
Current Ratio2.07
Quick Ratio2.07
Revenue 5Y-100.00%
Target$17.90
Target Upside790.55%
Target Median$21.00
Target Range1.50 - 38.00
Volume498.52K
Avg Volume1.29M
EPS Surprise-0.02
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score▼
Manageable debt level · 0.2Healthy liquidity · 2.07Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
93/100
Bullish
Bullish
6
Hold
1
Bearish
0
Price Target
2026-08-13
Low
$1.50
Mean
$17.90
Median
$21.00
High
$38.00
Insider Transactions
Recent executive and insider activity
Klencke Barbara
Transaction: 04/16/2026
BUY
Change
+100,000
Price
$1.68
Filing
04/17/2026
Type
BUY
Knight Jeff E.
Transaction: 04/16/2026
BUY
Change
+800,000
Price
$1.68
Filing
04/17/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Wong Shelly | SELL | -1,404 | $2.04 | 07/01/2026 | 07/06/2026 |
| Klencke Barbara | BUY | +100,000 | $1.68 | 04/16/2026 | 04/17/2026 |
| Knight Jeff E. | BUY | +800,000 | $1.68 | 04/16/2026 | 04/17/2026 |
| Knight Jeff E. | OTHER | 0 | Not reported | 04/13/2026 | 04/17/2026 |
| Pinto Shelly | SELL | -903 | $2.17 | 03/19/2026 | 03/23/2026 |
| Lettmann Jason | SELL | -12,311 | $2.17 | 03/19/2026 | 03/23/2026 |
| Klencke Barbara | BUY | +700,000 | $2.07 | 03/03/2026 | 03/05/2026 |
| Klencke Barbara | OTHER | +100,000 | $1.48 | 02/25/2026 | 03/05/2026 |
| Klencke Barbara | OTHER | 0 | Not reported | 02/25/2026 | 03/05/2026 |
| Pinto Shelly | SELL | -565 | $2.27 | 02/18/2026 | 02/20/2026 |
| Lettmann Jason | SELL | -2,201 | $2.27 | 02/17/2026 | 02/19/2026 |
| GOODMAN COREY S | BUY | +3,184,713 | $1.57 | 02/02/2026 | 02/04/2026 |
| Lettmann Jason | BUY | +912,000 | $1.48 | 01/26/2026 | 01/28/2026 |
| Pinto Shelly | BUY | +192,000 | $1.48 | 01/26/2026 | 01/28/2026 |
| Shantharam Harish | BUY | +303,000 | $1.48 | 01/26/2026 | 01/28/2026 |
| Hemrajani Rekha | BUY | +40,400 | $1.32 | 01/20/2026 | 01/21/2026 |
| Takimoto Chris H | BUY | +40,400 | $1.32 | 01/20/2026 | 01/21/2026 |
| Curran Daniel J. | BUY | +16,833 | $1.32 | 01/20/2026 | 01/21/2026 |
| Sandler Alan B. | BUY | +10,100 | $1.32 | 01/20/2026 | 01/21/2026 |
| Garland J. Scott | BUY | +40,400 | $1.32 | 01/20/2026 | 01/21/2026 |